상세 보기
Statin and aspirin for chemoprevention of hepato- cellular carcinoma: Time to use or wait further?
WEB OF SCIENCE
28SCOPUS
29초록
Preclinical studies highlighted potential therapeutic applications of aspirin and statins as anticancer agents based on their pleiotropic effects. Epidemiologic studies suggested the role of aspirin and statins in the chemoprevention of hepatocellular carcinoma (HCC). However, observational data is prone to bias, and no prospective randomized trials are currently available to assess the risks and benefits of statin or aspirin therapy for chemoprevention of HCC. It is therefore important for clinicians and researchers to be aware of the quality of current evidence regarding this issue. In this review, we summarize currently available evidence to assist clinicians with their decision to use statin or aspirin and provide information for further clinical investigations. (Clin Mol Hepatol 2022;28:380-395)
키워드
- 제목
- Statin and aspirin for chemoprevention of hepato- cellular carcinoma: Time to use or wait further?
- 저자
- Goh, Myung Ji; Sinn, Dong Hyun
- 발행일
- 2022-07
- 유형
- Review
- 권
- 28
- 호
- 3
- 페이지
- 380 ~ 395
- 언어
- ENG
- 출판사
- 대한간학회
- 발행국가
- 대한민국
- 분량
- 16 페이지
- ISSN
- E 2287-285X
P 2287-2728